# Telmisartan, Amlodipine and Flow Mediated Dilation

> **NCT01180205** · PHASE4 · UNKNOWN · sponsor: **Johannes Gutenberg University Mainz** · enrollment: 576 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Amlodipine
- **DRUG:** Olmesartan medoxomil
- **DRUG:** Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT01180205
- **Lead sponsor:** Johannes Gutenberg University Mainz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 576 (ESTIMATED)
- **Last updated:** 2011-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01180205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01180205, "Telmisartan, Amlodipine and Flow Mediated Dilation". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01180205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*